top of page

ABOUT US

CAPITAL PARTNER

Validating the vision and propelling growth

As a Blackstone Life Sciences portfolio company, Uniquity Bio has the capital resources to fund our clinical drug development, operations, and core capabilities. We operate independently under the Blackstone umbrella and enjoy a partnership that extends beyond capital investment to include scientific support and a shared commitment to excellence.

Nexstone-Immunology-Capital-Partner.jpg
Blackstone’s investment supports the value creation of individual drug assets while fueling pipeline growth, operational agility, and clinical execution.

As a nimble startup with experienced leaders and capital resources, Uniquity Bio is well-positioned to develop promising therapeutics and deliver important new medicines to patients.

By clicking any links on this page, you acknowledge that you are leaving Uniquity Bio’s website and accessing a third‑party website at your own risk

bottom of page